News & Updates

Product Highlight - Mibeaz

29 Sep 2021

Ezetimibe 10 mg Tablet

Product Highlight - Mibeaz

29 Sep 2021

DPP-4–to–SGLT2 inhibitor switch confers multiple benefits for patients with diabetes, hypertension

28 Sep 2021 by

In the treatment of patients with type 2 diabetes mellitus and hypertension, switching from a dipeptidyl peptidase-4 (DPP-4) inhibitor to the sodium-glucose cotransporter-2 (SGLT2) inhibitor luseogliflozin appears to have favourable effects on blood pressure (BP), circadian rhythm, and night-time systolic BP (SBP) and pulse rate (PR), according to data from the open-label LUNA trial.

DPP-4–to–SGLT2 inhibitor switch confers multiple benefits for patients with diabetes, hypertension

28 Sep 2021

Pharmacists must educate public on correct antibiotic use, says study

28 Sep 2021

A recent study has found gaps in patient knowledge regarding appropriate antibiotic use and delayed prescribing, which can serve as an opportunity for community pharmacists to educate these people and become involved in outpatient antibiotic stewardship.

Pharmacists must educate public on correct antibiotic use, says study

28 Sep 2021

Pharmacist-led diabetes clinic improves health outcomes of detainees

28 Sep 2021

The addition of a pharmacist-led diabetes clinic (PLDC) to multidisciplinary care teams in a correctional facility can potentially improve population health outcomes in underserved patients, suggests a study.

Pharmacist-led diabetes clinic improves health outcomes of detainees

28 Sep 2021

NSAIDs: suitable prophylaxis after cataract surgery?

28 Sep 2021 by

The addition of corticosteroids (ie, prednisolone) to NSAID eyedrops (ie, ketorolac) did not provide additional benefit relative to ketorolac alone or dropless surgery using a sub-Tenon capsule depot as an anti-inflammatory prophylactic regimen to prevent postoperative central macular thickening following uncomplicated cataract surgery, a Danish study suggests.

NSAIDs: suitable prophylaxis after cataract surgery?

28 Sep 2021

Lung function more stable but death risk higher in advanced IPF patients on antifibrotics

27 Sep 2021

Patients with advanced idiopathic pulmonary fibrosis (IPF) at the time of initiation with nintedanib or pirfenidone demonstrate more stable lung function over time, but substantially higher risk of death, compared to those with mild-to-moderate IPF, according to the results of a recent study.

Lung function more stable but death risk higher in advanced IPF patients on antifibrotics

27 Sep 2021

Further data back COVID booster shot in transplant patients

26 Sep 2021 by

Antibody response was significantly enhanced with a third dose of mRNA-1273 vaccine in organ transplant recipients, reveal data of a randomized trial.

Further data back COVID booster shot in transplant patients

26 Sep 2021

Long-term risk of anticoagulant-related bleeding high in patients with first unprovoked VTE

26 Sep 2021

There appears to be substantial long-term risks and consequences of anticoagulant-related major bleeding in patients with a first unprovoked venous thromboembolism (VTE), suggests a recent study.

Long-term risk of anticoagulant-related bleeding high in patients with first unprovoked VTE

26 Sep 2021

Add-on bempedoic acid may benefit patients with statin intolerance

26 Sep 2021

Bempedoic acid may be a boon to patients with full statin intolerance, as its addition can lessen the need for proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors and serve as a less expensive alternative to established oral lipid-lowering medications, according to a study.

Add-on bempedoic acid may benefit patients with statin intolerance

26 Sep 2021

Finerenone CV benefit extends to wide spectrum of CKD patients with T2D: FIGARO-DKD

25 Sep 2021 by

The large, phase III FIGARO-DKD trial strengthen the evidence on cardiovascular benefit (CV) of the nonsteroidal mineralocorticoid receptor (MR) antagonist finerenone, in addition to its renal benefit, across a wide spectrum of patients with type 2 diabetes (T2D) and chronic kidney disease (CKD).

Finerenone CV benefit extends to wide spectrum of CKD patients with T2D: FIGARO-DKD

25 Sep 2021

News & Updates

Filter by Specialty:

Specialty:

Product Highlight - Mibeaz

Product Highlight - Mibeaz

DPP-4–to–SGLT2 inhibitor switch confers multiple benefits for patients with diabetes, hypertension

DPP-4–to–SGLT2 inhibitor switch confers multiple benefits for patients with diabetes, hypertension

Pharmacists must educate public on correct antibiotic use, says study

Pharmacists must educate public on correct antibiotic use, says study

Pharmacist-led diabetes clinic improves health outcomes of detainees

Pharmacist-led diabetes clinic improves health outcomes of detainees

NSAIDs: suitable prophylaxis after cataract surgery?

NSAIDs: suitable prophylaxis after cataract surgery?

Lung function more stable but death risk higher in advanced IPF patients on antifibrotics

Lung function more stable but death risk higher in advanced IPF patients on antifibrotics

Further data back COVID booster shot in transplant patients

Further data back COVID booster shot in transplant patients

Long-term risk of anticoagulant-related bleeding high in patients with first unprovoked VTE

Long-term risk of anticoagulant-related bleeding high in patients with first unprovoked VTE

Add-on bempedoic acid may benefit patients with statin intolerance

Add-on bempedoic acid may benefit patients with statin intolerance

Finerenone CV benefit extends to wide spectrum of CKD patients with T2D: FIGARO-DKD

Finerenone CV benefit extends to wide spectrum of CKD patients with T2D: FIGARO-DKD